Gao Shan

Gao Shan

Aarhus Universitet

H-index: 34

Europe-Denmark

About Gao Shan

Gao Shan, With an exceptional h-index of 34 and a recent h-index of 24 (since 2020), a distinguished researcher at Aarhus Universitet, specializes in the field of Oral Cancer、RNAi, Drug Delviery....

His recent articles reflect a diverse array of research interests and contributions to the field:

Targeting ANGPTL3 by GalNAc-conjugated siRNA ANGsiR10 lowers blood lipids with long-lasting and potent efficacy in mice and monkeys

Inhibition of Factor XI using a GalNAc-siRNA RBD5049: a novel antithrombotic drug with high potency and long duration

RBD5044-a novel anti-ApoC3 GalNAc-siRNA drug resulted in sustained and profound reduction of triglycerides in mice and Rhesus monkeys

RBD1016 A Novel Anti-HBV GalNAc-siRNA Drug Resulted in Sustained HBsAg Reduction and Seroconversion in Mice Models

My 20 years together with Journal of Oral Pathology and Medicine

Research progress of tumor targeted drug delivery based on PD-1/PD-L1

Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B

Long‐term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3‐years follow‐up study

Gao Shan Information

University

Position

___

Citations(all)

4222

Citations(since 2020)

1574

Cited By

3236

hIndex(all)

34

hIndex(since 2020)

24

i10Index(all)

56

i10Index(since 2020)

44

Email

University Profile Page

Aarhus Universitet

Google Scholar

View Google Scholar Profile

Gao Shan Skills & Research Interests

Oral Cancer、RNAi

Drug Delviery...

Top articles of Gao Shan

Title

Journal

Author(s)

Publication Date

Targeting ANGPTL3 by GalNAc-conjugated siRNA ANGsiR10 lowers blood lipids with long-lasting and potent efficacy in mice and monkeys

Molecular Therapy-Nucleic Acids

Jue Wang

Wen Zheng

Shuquan Zheng

Ye Yuan

Wei Wen

...

2023/3/14

Inhibition of Factor XI using a GalNAc-siRNA RBD5049: a novel antithrombotic drug with high potency and long duration

European Heart Journal

L Gan

C Li

Y Sun

J Wikstrom

Z Guo

...

2023/11

RBD5044-a novel anti-ApoC3 GalNAc-siRNA drug resulted in sustained and profound reduction of triglycerides in mice and Rhesus monkeys

European Heart Journal

S Gao

H Luo

Z Guo

S Zheng

J Wikstrom

...

2023/11

RBD1016 A Novel Anti-HBV GalNAc-siRNA Drug Resulted in Sustained HBsAg Reduction and Seroconversion in Mice Models

S ZHENG

H Li

Z GUO

H YU

C Tong

...

2023/6/1

My 20 years together with Journal of Oral Pathology and Medicine

Shan Gao

2023/4

Research progress of tumor targeted drug delivery based on PD-1/PD-L1

Dongzhu Liu

Shan Gao

Yujia Zhai

Xiaoye Yang

Guangxi Zhai

2022/3/25

Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B

Signal transduction and targeted therapy

Yuanyu Huang

Shuquan Zheng

Zhaoxu Guo

Xavier de Mollerat du Jeu

Xing-Jie Liang

...

2022/2/11

Long‐term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3‐years follow‐up study

Journal of Oral Pathology & Medicine

Gururaj Arakeri

Shankargouda Patil

Nagaraj Maddur

Vishal Rao US

Anand Subash

...

2020/9

Corrigendum for" Focal Adhesion Kinase knockdown in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis via Downregulating MCP-1/CCL2 Expression …

Journal of Biochemical and Molecular Toxicology

Anjie Min

Chao Zhu

Jingyi Wang

Shuping Peng

Cijun Shuai

...

2020/5/27

See List of Professors in Gao Shan University(Aarhus Universitet)